Skip to main content
Journal cover image

Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial.

Publication ,  Journal Article
Vemulapalli, S; Stebbins, A; Jones, WS; Gutierrez, JA; Patel, MR; Dolor, RJ; Pellikka, PA; Alhanti, B; Hoffmann, U; Douglas, PS
Published in: Am Heart J
December 2021

BACKGROUND: Non-coronary vascular disease (NCVD) is associated with adverse cardiovascular events. Little is known about physician risk assessment, prevalence of coronary artery disease (CAD), cardiac catheterization, and the performance of the atherosclerotic cardiovascular disease (ASCVD) risk score in patients with NCVD. METHODS: Retrospective analysis of outpatients with angina and no known CAD from the PROMISE trial. NCVD included carotid artery stenosis ≥50%, or history of stroke or peripheral artery disease. Multivariable models of physician estimates of the probability of obstructive CAD, prevalence of non-obstructive and obstructive CAD, referral to cardiac catheterization, and all-cause death/myocardial infarction/unstable angina were performed. RESULTS: Among 10,001 patients in the PROMISE trial, 379 (3.8%) patients had NCVD. Only 8.5% of participants with NCVD were categorized as high-risk for obstructive CAD by physicians, though 15.5% (25/161) had obstructive CAD in those randomized to coronary computed tomography (CTA). NCVD was independently associated with non-obstructive (aOR = 1.58; 95% CI 1.18-2.61; P = .006) but not obstructive CAD by CTA. Adjusted referral to cardiac catheterization was similar with and without NCVD (aOR 1.04; 95% CI 0.88-1.94, P = .19). NCVD was associated with an increased risk of all-cause death/MI/UA (aOR 2.03; 95% CI 1.37-3.01, P < .001). There was no interaction between NCVD status and ASCVD risk score. CONCLUSIONS: Among patients with NCVD and angina, NCVD had increased adjusted risks of CAD and adverse outcomes which were not well described by ASCVD risk score and were underrecognized by physicians. Increased awareness and better risk stratification tools for patients with NCVD may be necessary to recognize the associated CV risk and optimize diagnostic testing and therapies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

December 2021

Volume

242

Start / End Page

82 / 91

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Humans
  • Heart Disease Risk Factors
  • Coronary Artery Disease
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vemulapalli, S., Stebbins, A., Jones, W. S., Gutierrez, J. A., Patel, M. R., Dolor, R. J., … Douglas, P. S. (2021). Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial. Am Heart J, 242, 82–91. https://doi.org/10.1016/j.ahj.2021.07.010
Vemulapalli, Sreekanth, Amanda Stebbins, W Schuyler Jones, J Antonio Gutierrez, Manesh R. Patel, Rowena J. Dolor, Patricia A. Pellikka, Brooke Alhanti, Udo Hoffmann, and Pamela S. Douglas. “Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial.Am Heart J 242 (December 2021): 82–91. https://doi.org/10.1016/j.ahj.2021.07.010.
Vemulapalli S, Stebbins A, Jones WS, Gutierrez JA, Patel MR, Dolor RJ, et al. Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial. Am Heart J. 2021 Dec;242:82–91.
Vemulapalli, Sreekanth, et al. “Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial.Am Heart J, vol. 242, Dec. 2021, pp. 82–91. Pubmed, doi:10.1016/j.ahj.2021.07.010.
Vemulapalli S, Stebbins A, Jones WS, Gutierrez JA, Patel MR, Dolor RJ, Pellikka PA, Alhanti B, Hoffmann U, Douglas PS. Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial. Am Heart J. 2021 Dec;242:82–91.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

December 2021

Volume

242

Start / End Page

82 / 91

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Humans
  • Heart Disease Risk Factors
  • Coronary Artery Disease
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology